首页> 外文期刊>Biochimica et Biophysica Acta. General Subjects >Mechanism of neopterin-induced myocardial dysfunction in the isolated perfused rat heart
【24h】

Mechanism of neopterin-induced myocardial dysfunction in the isolated perfused rat heart

机译:新蝶呤诱导的离体灌流大鼠心脏心肌功能障碍的机制

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Neopterin is a sensitive marker for diseases involving increased activity of the cellular immune system in humans. Many studies, however, provide evidence for neopterin not only as a marker, but also for its characteristic effects. Recently, we were able to demonstrate a considerable influence of exogenous neopterin at a concentration of 100 mu mol/l on cardiac performance in the Langendorff model of isolated perfused rat hearts. The present study was designed to investigate its possible mechanism.During co-infusion of neopterin at a concentration of 100 mu molA with the unspecific nitric oxide synthase inhibitor N-G-monomethyl-L-arginine monoacetate, the nitric oxide donor PAPA NONOate, the free radical scavenger N-acetylcysteine, or the pro-inflammatory cytokine tumor necrosis factor-alpha the effects on cardiac contractility parameters and coronary vascular resistance were studied in 67 male Sprague-Dawley rats. The temperature-controlled and pressure-constant Langendorff apparatus was used with retrograde perfusion of the aorta and a Krebs-Henseleit buffer.Neither the unspecific nitric oxide synthase inhibitor nor the nitric oxide donor excludes nitric oxide from playing a mechanistic role in our perfusion studies. Tumor necrosis factor-alpha was without any synergistic or antagonistic effects when co-treated with neopterin. N-acetylcysteine was most effective in abolishing neopterin-dependent effects on cardiac function.The negative effects of neopterin on cardiac performance might be due to an enhancement of oxidative stress by neopterin that can be attenuated by the antioxidant N-acetylcysteine. Neopterin has to be considered a pathogenic factor in the development of cardiac dysfunction in chronic disease states with high neopterin levels secondary to activation of the immune system. (c) 2005 Elsevier B.V. All rights reserved.
机译:新蝶呤是涉及人类细胞免疫系统活性增强的疾病的敏感标记。然而,许多研究不仅为新蝶呤提供了证据,而且还为其特征性作用提供了证据。最近,我们能够在离体灌流大鼠心脏的Langendorff模型中证明浓度为100μmol/ l的外源新蝶呤对心脏性能的显着影响。本研究旨在研究其可能的机制。在将新蝶呤以100μmolA的浓度与非特异性一氧化氮合酶抑制剂NG-单甲基-L-精氨酸单乙酸酯,一氧化氮供体PAPA NONOate,自由基共注入期间在67只雄性Sprague-Dawley大鼠中研究了清道夫N-乙酰半胱氨酸或促炎性细胞因子肿瘤坏死因子-α对心脏收缩参数和冠状动脉血管阻力的影响。温度控制和压力恒定的Langendorff仪器用于主动脉和Krebs-Henseleit缓冲液的逆行灌注,无论是非特异性一氧化氮合酶抑制剂还是一氧化氮供体都不能排除一氧化氮在我们的灌注研究中的作用。与新蝶呤共同治疗时,肿瘤坏死因子-α没有任何协同或拮抗作用。 N-乙酰半胱氨酸在消除新蝶呤对心脏功能的影响方面最有效。新蝶呤对心脏功能的负面影响可能是由于新蝶呤增强了氧化应激,而抗氧化剂N-乙酰半胱氨酸可以减轻这种氧化应激。新蝶呤必须被认为是慢性疾病状态下心脏功能障碍发展的致病因素,其继发于免疫系统激活的新蝶呤水平较高。 (c)2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号